Cargando…

In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays

BACKGROUND: Pyronaridine, a Mannich base anti-malarial with high efficacy against drug resistant Plasmodium falciparum, is currently evaluated as a fixed dose combination with artesunate for the treatment of uncomplicated malaria. In this study, the in vitro activity of pyronaridine against clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurth, Florian, Pongratz, Peter, Bélard, Sabine, Mordmüller, Benjamin, Kremsner, Peter G, Ramharter, Michael
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679051/ https://www.ncbi.nlm.nih.gov/pubmed/19389221 http://dx.doi.org/10.1186/1475-2875-8-79

Ejemplares similares

Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
por: Pascual, Aurélie, et al.
Publicado: (2015)

Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine
por: Kritsiriwuthinan, Kanyanan, et al.
Publicado: (2011)

Life-span of in vitro differentiated Plasmodium falciparum gametocytes
por: Gebru, Tamirat, et al.
Publicado: (2017)

In vitro growth of Plasmodium falciparum in neonatal blood
por: Sauerzopf, Ulrich, et al.
Publicado: (2014)

Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon
por: Mombo-Ngoma, Ghyslain, et al.
Publicado: (2012)

Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
por: Koehne, Erik, et al.
Publicado: (2021)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2019)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2022)

Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
por: Koehne, Erik, et al.
Publicado: (2022)

Review of pyronaridine anti-malarial properties and product characteristics
por: Croft, Simon L, et al.
Publicado: (2012)

Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing
por: Lalremruata, Albert, et al.
Publicado: (2017)

Effect of mild medical hypothermia on in vitro growth of Plasmodium falciparum and the activity of anti-malarial drugs
por: Rehman, Khalid, et al.
Publicado: (2016)

Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
por: Bukirwa, Hasifa, et al.
Publicado: (2014)

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
por: Monatrakul, Preeyaporn, et al.
Publicado: (2010)

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
por: Kurth, Florian, et al.
Publicado: (2016)

Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon
por: Kreidenweiss, Andrea, et al.
Publicado: (2008)

Efficacy and Safety of Pyronaridine–Artesunate for the Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax Malaria in Myanmar
por: Han, Kay Thwe, et al.
Publicado: (2020)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
por: Roth, Johanna M., et al.
Publicado: (2018)

Paediatric formulations of artemisinin‐based combination therapies for treating uncomplicated malaria in children
por: Bélard, Sabine, et al.
Publicado: (2020)

Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum
por: Pradines, Bruno, et al.
Publicado: (2010)

THE CULTIVATION OF MALARIAL PLASMODIA (PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM) IN VITRO
por: Bass, C. C., et al.
Publicado: (1912)

Assessment of LED fluorescence microscopy for the diagnosis of Plasmodium falciparum infections in Gabon
por: Lenz, Dominic, et al.
Publicado: (2011)

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016)

Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial
por: Kayentao, Kassoum, et al.
Publicado: (2012)

Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection
por: Mombo-Ngoma, Ghyslain, et al.
Publicado: (2011)

Adolescence As Risk Factor for Adverse Pregnancy Outcome in Central Africa – A Cross-Sectional Study
por: Kurth, Florian, et al.
Publicado: (2010)

Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum
por: de Carvalho, Laís Pessanha, et al.
Publicado: (2022)

Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials
por: Combrinck, Jill M., et al.
Publicado: (2015)

Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum
por: Le Manach, Claire, et al.
Publicado: (2013)

Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients
por: Ayyoub, Amal, et al.
Publicado: (2016)

Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil
por: Aguiar, Anna Caroline C, et al.
Publicado: (2014)

A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs
por: Quashie, Neils B, et al.
Publicado: (2013)

DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon
por: Nguyen, The Trong, et al.
Publicado: (2019)

In vitro studies on the sensitivity pattern of Plasmodium falciparum to anti-malarial drugs and local herbal extracts
por: Olasehinde, Grace I, et al.
Publicado: (2014)

Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs
por: Pascual, Aurélie, et al.
Publicado: (2011)

Therapeutic efficacy of pyronaridine-artesunate (Pyramax(®)) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia
por: Alebachew, Mihreteab, et al.
Publicado: (2023)

Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice
por: SheelaNair, Arya, et al.
Publicado: (2022)

Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children
por: Sowunmi, Akintunde, et al.
Publicado: (2011)

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
por: Peatey, Christopher L, et al.
Publicado: (2012)

Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs
por: Fall, Bécaye, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7j8fv4rcmnvuk0p4td2o3k2upg